(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

SUBOXONE (BUPRENORPHINE AND NALOXONE) C SUBLINGUAL FILM

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

SUBOXONE (BUPRENORPHINE AND NALOXONE) C SUBLINGUAL FILM

ST13

US500000085332074

Class

16, 44

Filing

85332074

Registration

4101625

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

58

Latest update

11/20/2024

Trademark type

Combined

Nice classes

16, 44

Filing date

05/27/2011

Registration date

02/21/2012

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

04/11/2022

Last transaction

09/18/2023

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Principal Register

First use anywhere

09/15/2010

First use in commerce

09/15/2010

Drawing code

3

Owner type

99

Owner location

Hull, GB

Examiner

WILKE, JOHN

Law office

L40

Current location

GENERIC WEB UPDATE

Mark description

The mark consists of the stylized word "Suboxone" in blue. The chemical name of the mark "(buprenorphine and naloxone)" appears in blue underneath the word "Suboxone". To the right of the chemical name is a stylized "C" with three vertical lines inside in blue, followed by the words "Sublingual Film" in green.

Holders and representatives

Holders

INDIVIOR UK LIMITED
RB PHARMACEUTICALS LIMITED
Reckitt Benckiser Healthcare (UK) Limited

Representatives

Shauna M. Wertheim The Marbury Law Group, PLLC

Technical classification

Nice Classes

Class 16Class 44

Vienna Codes

No Vienna codes available.

Goods and services

Class 16

Printed matterinformation cardsleaflets and pamphlets in the field of opioid dependence and its treatment

Class 44

Provision of health care advice; providing information relating to opioid dependence

Publications

History of USPTO decisions and trademark events.

58 publications found

ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

11/20/2024

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

09/18/2023

ECDR

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

09/18/2023

EWOR

TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED

09/18/2023

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

09/18/2023

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

09/18/2023

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

09/18/2023

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

09/18/2023

WOAG

WITHDRAWAL OF ATTORNEY GRANTED

08/31/2023

WOAR

TEAS WITHDRAWAL OF ATTORNEY RECEIVED

08/31/2023

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

08/30/2023

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

08/30/2023

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

08/30/2023

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

08/30/2023

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

08/30/2023

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

04/11/2022

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

04/11/2022

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

04/11/2022

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

04/11/2022

E89R

TEAS SECTION 8 & 9 RECEIVED

12/13/2021

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

02/21/2021

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

01/29/2019

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

01/29/2019

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

10/18/2018

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

10/18/2018

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

02/18/2018

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

02/17/2018

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

02/16/2018

E815

TEAS SECTION 8 & 15 RECEIVED

02/05/2018

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

02/21/2017

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

08/19/2015

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

02/27/2015

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

02/27/2015

ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

12/31/2014

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

02/12/2014

R.PR

REGISTERED-PRINCIPAL REGISTER

02/21/2012

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

12/06/2011

PUBO

PUBLISHED FOR OPPOSITION

12/06/2011

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

11/16/2011

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

11/01/2011

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

11/01/2011

XAEC

EXAMINER'S AMENDMENT ENTERED

11/01/2011

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

11/01/2011

GNEA

EXAMINERS AMENDMENT E-MAILED

11/01/2011

CNEA

EXAMINERS AMENDMENT -WRITTEN

11/01/2011

ZZZX

PREVIOUS ALLOWANCE COUNT WITHDRAWN

10/28/2011

PBCR

WITHDRAWN FROM PUB - OG REVIEW QUERY

10/18/2011

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

10/03/2011

ALIE

ASSIGNED TO LIE

09/28/2011

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

09/16/2011

XAEC

EXAMINER'S AMENDMENT ENTERED

09/16/2011

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

09/16/2011

GNEA

EXAMINERS AMENDMENT E-MAILED

09/16/2011

CNEA

EXAMINERS AMENDMENT -WRITTEN

09/16/2011

DOCK

ASSIGNED TO EXAMINER

09/14/2011

MDSC

NOTICE OF DESIGN SEARCH CODE MAILED

06/03/2011

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

06/02/2011

NWAP

NEW APPLICATION ENTERED

05/31/2011

Continuous trademark protection

Get notified about every new filing that threatens SUBOXONE (BUPRENORPHINE AND NALOXONE) C SUBLINGUAL FILM or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.